Use of modified cyclosporins

Details for Australian Patent Application No. 2007306316 (hide)

Owner Novartis AG Kyushu University

Inventors Kohjima, Motoyuki; Nakamuta, Makoto

Agent Davies Collison Cave

Pub. Number AU-B-2007306316

PCT Pub. Number WO2008/043797

Priority 60/829,228 12.10.06 US

Filing date 10 October 2007

Wipo publication date 17 April 2008

Acceptance publication date 27 October 2011

International Classifications

A61K 38/13 (2006.01) Medicinal preparations containing peptides

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

14 May 2009 PCT application entered the National Phase

  PCT publication WO2008/043797 Priority application(s): WO2008/043797

27 October 2011 Application Accepted

  Published as AU-B-2007306316

23 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007306318-Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound

2007306312-Hearing aid having an occlusion reduction unit, and method for occlusion reduction